RT Journal Article
SR Electronic
T1 Meta-analysis of Genome wide Association Studies on Childhood ADHD Symptoms and Diagnosis Reveals 17 Novel Loci and 22 Potential Effector Genes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.17.24305817
DO 10.1101/2024.04.17.24305817
A1 Van der Laan, Camiel M.
A1 Ip, Hill F.
A1 Schipper, Marijn
A1 Hottenga, Jouke-Jan
A1 Krapohl, Eva M. L.
A1 Brikell, Isabell
A1 Soler Artigas, María
A1 Cabana-Domínguez, Judith
A1 Natalia, Llonga
A1 Nolte, Ilja M.
A1 St Pourcain, Beate
A1 Bolhuis, Koen
A1 Palviainen, Teemu
A1 Zafarmand, Hadi
A1 Gordon, Scott
A1 Zayats, Tetyana
A1 Aliev, Fazil
A1 Burt, Alexandra S.
A1 Wang, Carol A.
A1 Saunders, Gretchen
A1 Karhunen, Ville
A1 Adkins, Daniel E.
A1 Border, Richard
A1 Peterson, Roseann E.
A1 Prinz, Joseph A.
A1 Thiering, Elisabeth
A1 Vilor-Tejedor, Natàlia
A1 Ahluwalia, Tarunveer S.
A1 Allegrini, Andrea
A1 Rimfeld, Kaili
A1 Chen, Qi
A1 Lu, Yi
A1 Martin, Joanna
A1 Bosch, Rosa
A1 Ramos Quiroga, Josep Antoni
A1 Neumann, Alexander
A1 Ensink, Judith
A1 Grasby, Katrina
A1 Morosoli, José J.
A1 Tong, Xiaoran
A1 Marrington, Shelby
A1 Scott, James G.
A1 Shabalin, Andrey A.
A1 Corley, Robin
A1 Evans, Luke M.
A1 Sugden, Karen
A1 Alemany, Silvia
A1 Sass, Lærke
A1 Vinding, Rebecca
A1 Ehli, Erik A.
A1 Hagenbeek, Fiona A.
A1 Derks, Eske
A1 Larsson, Henrik
A1 Snieder, Harold
A1 Cecil, Charlotte
A1 Whipp, Alyce M.
A1 Korhonen, Tellervo
A1 Vuoksimaa, Eero
A1 Rose, Richard J.
A1 Uitterlinden, André G.
A1 Haavik, Jan
A1 Harris, Jennifer R.
A1 Helgeland, Øyvind
A1 Johansson, Stefan
A1 Knudsen, Gun Peggy S.
A1 Njolstad, Pal Rasmus
A1 Lu, Qing
A1 Rodriguez, Alina
A1 Henders, Anjali K.
A1 Mamun, Abdullah
A1 Najman, Jackob M.
A1 Brown, Sandy
A1 Hopfer, Christian
A1 Krauter, Kenneth
A1 Reynolds, Chandra
A1 Smolen, Andrew
A1 Stallings, Michael
A1 Wadsworth, Sally
A1 Wall, Tamara
A1 Eaves, Lindon
A1 Silberg, Judy L.
A1 Miller, Allison
A1 Havdahl, Alexandra
A1 Llop, Sabrina
A1 Lopez-Espinosa, Maria-Jose
A1 Bønnelykke, Klaus
A1 Sunyer, Jordi
A1 Arseneault, Louise
A1 Standl, Marie
A1 Heinrich, Joachim
A1 Boden, Joseph
A1 Pearson, John
A1 Horwood, John
A1 Kennedy, Martin
A1 Poulton, Richie
A1 Maes, Hermine H.
A1 Hewitt, John
A1 Copeland, William E.
A1 Middeldorp, Christel M.
A1 Williams, Gail M.
A1 Wray, Naomi
A1 Järvelin, Marjo-Riitta
A1 McGue, Matt
A1 Iacono, William
A1 Caspi, Avshalom
A1 Moffitt, Terrie E.
A1 Whitehouse, Andrew
A1 Pennell, Craig E.
A1 Klump, Kelly L.
A1 Jiang, Chang
A1 Dick, Danielle M.
A1 Reichborn-Kjennerud, Ted
A1 Martin, Nicholas G.
A1 Medland, Sarah E.
A1 Vrijkotte, Tanja
A1 Kaprio, Jaakko
A1 Tiemeier, Henning
A1 Davey Smith, George
A1 Hartman, Catharina A.
A1 Oldehinkel, Albertine J.
A1 Casas, Miquel
A1 Ribasés, Marta
A1 Lichtenstein, Paul
A1 Lundström, Sebastian
A1 Plomin, Robert
A1 Bartels, Meike
A1 Nivard, Michel G.
A1 Boomsma, Dorret I.
YR 2024
UL http://medrxiv.org/content/early/2024/04/19/2024.04.17.24305817.abstract
AB Attention-deficit/hyperactivity disorder (ADHD) is a heritable neurodevelopmental disorder for which genetic factors explain up to 75% of the variance. In this study, we performed a genome-wide association meta-analysis (GWAMA) of ADHD symptom measures, with an effective sample size of 120,092 (71,733 unique individuals from 28 population-based cohorts, with 288,887 quantitative ADHD symptom measures). Next, we meta-analyzed the results with a genome-wide association study (GWAS) of ADHD diagnosis. The GWAMA of ADHD symptoms returned no genome-wide significant variants. However, we estimated strong genetic correlations between our study of quantitative ADHD symptoms and the earlier study of ADHD diagnosis (rg= 1.00, SE= 0.06). Moderate negative genetic correlations (rg< -0.40) were observed with several cognitive traits. Genetic correlations between ADHD and aggressive behavior and antisocial behavior were around 1. This provides further evidence of the wide pleiotropic effects of genetic variants and the role that genetic variants play in the co-occurrence with (mental) health traits. The GWAMAs of ADHD symptoms and diagnosis identified 2,039 genome-wide significant variants, representing 39 independent loci, of which 17 were new. Using a novel fine-mapping and functional annotation method, we identified 22 potential effector genes which implicate several new potential biological processes and pathways that may play a role in ADHD. Our findings support the notion that clinical ADHD is at the extreme end of a continuous liability that is indexed by ADHD symptoms. We show that including ADHD symptom counts in large-scale GWAS can be useful to identify novel genes implicated in ADHD and related symptoms.Competing Interest StatementJ.A.R.Q. was on the speakers bureau and/or acted as consultant for Biogen, Idorsia, Casen-Recordati, Janssen-Cilag, Novartis, Takeda, Bial, Sincrolab, Neuraxpharm, Novartis, BMS, Medice, Rubio, Uriach, Technofarma and Raffo in the last 3 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Idorsia, Janssen-Cilag, Rubio, Takeda, Bial and Medice. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following companies in the last 3 years: Exeltis, Idorsia, Janssen-Cilag, Neuraxpharm, Oryzon, Roche, Probitas and Rubio. M.C. has received fees to give talks for TAKEDA and Laboratorios RUBIO. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.Clinical Protocols https://www.action-euproject.eu/sites/default/files/Action%20AGG%20AP%20SOP.pdf Funding StatementThe project was supported by the Aggression in Children: Unraveling gene-environment interplay to inform Treatment and InterventiON strategies project (ACTION). ACTION received funding from the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement no 602768. Cohort-specific acknowledgements and funding information are included in the Supplementary text.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study approval was obtained from the Central Ethics Committee on Research Involving Human Subjects of the VU University Medical Center, Amsterdam (NTR 25th of May 2007 and ACTION 2013/41 and 2014.252), an Institutional Review Board certified by the U.S. Office of Human Research Protections (IRB number IRB00002991 under Federal-wide Assurance-FWA00017598; IRB/institute codes).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at <link to follow>